NANOXPLORE INC (GRA.CA) Stock Fundamental Analysis
TSX:GRA - Toronto Stock Exchange - CA63010G1000 - Common Stock - Currency: CAD
GRA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 28 industry peers in the Chemicals industry. The financial health of GRA is average, but there are quite some concerns on its profitability. While showing a medium growth rate, GRA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year GRA has reported negative net income.
GRA had a positive operating cash flow in the past year.
In the past 5 years GRA always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: GRA reported negative operating cash flow in multiple years.
1.2 Ratios
GRA has a Return On Assets (-6.48%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -9.69%, GRA is in the better half of the industry, outperforming 60.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.48% | ||
| ROE | -9.69% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GRA's Gross Margin of 18.57% is in line compared to the rest of the industry. GRA outperforms 46.43% of its industry peers.
GRA's Gross Margin has improved in the last couple of years.
GRA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y46.47%
GM growth 5Y4.81%
2. Health
2.1 Basic Checks
GRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
GRA has more shares outstanding than it did 5 years ago.
2.2 Solvency
GRA has an Altman-Z score of 5.05. This indicates that GRA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of GRA (5.05) is better than 78.57% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that GRA is not too dependend on debt financing.
GRA has a Debt to Equity ratio of 0.14. This is amongst the best in the industry. GRA outperforms 82.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.05 |
ROIC/WACCN/A
WACC7.85%
2.3 Liquidity
A Current Ratio of 1.99 indicates that GRA should not have too much problems paying its short term obligations.
GRA has a Current ratio of 1.99. This is in the better half of the industry: GRA outperforms 67.86% of its industry peers.
GRA has a Quick Ratio of 1.44. This is a normal value and indicates that GRA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.44, GRA is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.99 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
GRA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Looking at the last year, GRA shows a quite strong growth in Revenue. The Revenue has grown by 9.12% in the last year.
GRA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.33% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)9.12%
Revenue growth 3Y24.8%
Revenue growth 5Y13.33%
Sales Q2Q%-10.1%
3.2 Future
GRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.59% yearly.
GRA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.87% yearly.
EPS Next Y15.83%
EPS Next 2Y36.23%
EPS Next 3Y45.72%
EPS Next 5Y29.59%
Revenue Next Year9.38%
Revenue Next 2Y16.93%
Revenue Next 3Y25.67%
Revenue Next 5Y17.87%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for GRA. In the last year negative earnings were reported.
Also next year GRA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
GRA's Enterprise Value to EBITDA is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 100.68 |
4.3 Compensation for Growth
GRA's earnings are expected to grow with 45.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.23%
EPS Next 3Y45.72%
5. Dividend
5.1 Amount
GRA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:GRA (7/4/2025, 7:00:00 PM)
2.355
-0.02 (-0.63%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners12.56%
Inst Owner ChangeN/A
Ins Owners7.38%
Ins Owner ChangeN/A
Market Cap401.79M
Analysts76
Price Target3.83 (62.63%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.99%
Min EPS beat(2)-53.98%
Max EPS beat(2)33.99%
EPS beat(4)2
Avg EPS beat(4)-8.63%
Min EPS beat(4)-53.98%
Max EPS beat(4)33.99%
EPS beat(8)4
Avg EPS beat(8)-15.47%
EPS beat(12)6
Avg EPS beat(12)-31.39%
EPS beat(16)7
Avg EPS beat(16)-61.64%
Revenue beat(2)0
Avg Revenue beat(2)-9.84%
Min Revenue beat(2)-14.65%
Max Revenue beat(2)-5.03%
Revenue beat(4)0
Avg Revenue beat(4)-6.39%
Min Revenue beat(4)-14.65%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-5.88%
Revenue beat(12)4
Avg Revenue beat(12)-2.77%
Revenue beat(16)5
Avg Revenue beat(16)-1.82%
PT rev (1m)-10.52%
PT rev (3m)-12.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-4.12%
Revenue NQ rev (3m)-17.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.97 | ||
| P/FCF | N/A | ||
| P/OCF | 91.75 | ||
| P/B | 3.98 | ||
| P/tB | 4.62 | ||
| EV/EBITDA | 100.68 |
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.03
OCFY1.09%
SpS0.79
BVpS0.59
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.48% | ||
| ROE | -9.69% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18.57% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y46.47%
GM growth 5Y4.81%
F-Score5
Asset Turnover0.9
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.63 | ||
| Cap/Depr | 108.56% | ||
| Cap/Sales | 8.99% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 109.67% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.99 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 5.05 |
F-Score5
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)78.57%
Cap/Depr(5y)156.07%
Cap/Sales(3y)6.19%
Cap/Sales(5y)12.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y15.83%
EPS Next 2Y36.23%
EPS Next 3Y45.72%
EPS Next 5Y29.59%
Revenue 1Y (TTM)9.12%
Revenue growth 3Y24.8%
Revenue growth 5Y13.33%
Sales Q2Q%-10.1%
Revenue Next Year9.38%
Revenue Next 2Y16.93%
Revenue Next 3Y25.67%
Revenue Next 5Y17.87%
EBIT growth 1Y44.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year143.09%
EBIT Next 3Y68.1%
EBIT Next 5Y71.57%
FCF growth 1Y23.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y248.81%
OCF growth 3YN/A
OCF growth 5YN/A